Parts I and II of the INSEAD Healthcare Compliance Implementation Leadership Programme are designed to benefit :
- Participants who are new to or have been recently assigned to the compliance function
- Experienced compliance professionals who desire to update, broaden and sharpen their knowledge and skills, and exchange experiences with colleagues from other companies, countries and regions of the world
Part III, the INSEAD Advanced Healthcare Compliance Implementation Leadership Programme is designed to benefit:
- Healthcare compliance officers with at least five years’ healthcare compliance experience
- Experienced participants who have attended the INSEAD Healthcare Compliance Implementation Leadership Programme I and/or II and are asking: What can I do to make increase my performance in my work? Where do I want to be in five years’ time?
Classes for the programmes are limited to a maximum of 35 participants.
Participants generally come from a broad range of countries. For example, the most recent INSEAD Healthcare Compliance Implementation Leadership Programme drew participants from 20 countries in Europe, Asia, Middle East and the Americas.
Organisations represented recently include: Amgen, ARIAD, AstraZeneca, Baxter, Biogen, Bristol-Myers Squibb, Ferring, F. Hoffmann-La Roche Ltd., Grünenthal, Genesis, GSK, IPSEN, Johnson & Johnson, Mylan, Merck, Norvatis, Napp, Novo Nordisk, Otsuka, Pfizer, Sanofi, Takeda, UCB, West-Ward, Zimmer.
The diversity of participants creates a unique environment at INSEAD and enriches participants’ learning experience.